These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 18183595
1. Rectal gastrointestinal stromal tumors associated with a novel germline KIT mutation. Woźniak A, Rutkowski P, Sciot R, Ruka W, Michej W, Debiec-Rychter M. Int J Cancer; 2008 May 01; 122(9):2160-4. PubMed ID: 18183595 [Abstract] [Full Text] [Related]
2. Imatinib in the management of multiple gastrointestinal stromal tumors associated with a germline KIT K642E mutation. Graham J, Debiec-Rychter M, Corless CL, Reid R, Davidson R, White JD. Arch Pathol Lab Med; 2007 Sep 01; 131(9):1393-6. PubMed ID: 17824795 [Abstract] [Full Text] [Related]
3. Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13. Bachet JB, Landi B, Laurent-Puig P, Italiano A, Le Cesne A, Lévy P, Safar V, Duffaud F, Blay JY, Emile JF. Eur J Cancer; 2013 Jul 01; 49(11):2531-41. PubMed ID: 23648119 [Abstract] [Full Text] [Related]
4. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Lasota J, Miettinen M. Semin Diagn Pathol; 2006 May 01; 23(2):91-102. PubMed ID: 17193822 [Abstract] [Full Text] [Related]
5. Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview. Farag S, van der Kolk LE, van Boven HH, van Akkooi ACJ, Beets GL, Wilmink JW, Steeghs N. Fam Cancer; 2018 Apr 01; 17(2):247-253. PubMed ID: 28710566 [Abstract] [Full Text] [Related]
8. Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: implications of imatinib mesylate. Yeh CN, Chen TW, Wu TJ, Hsueh S, Jan YY. World J Gastroenterol; 2006 Jun 21; 12(23):3760-5. PubMed ID: 16773696 [Abstract] [Full Text] [Related]
9. Familial and multiple gastrointestinal stromal tumors with fair response to a half-dose of imatinib. Bamba S, Hirota S, Inatomi O, Ban H, Nishimura T, Shioya M, Imaeda H, Nishida A, Sasaki M, Murata S, Andoh A. Intern Med; 2015 Jun 21; 54(7):759-64. PubMed ID: 25832938 [Abstract] [Full Text] [Related]
10. Neoadjuvant imatinib in a locally advanced gastrointestinal stromal tumour (GIST) of the rectum: a rare case of two GISTs within a family without a familial GIST syndrome. Mandalà M, Pezzica E, Tamborini E, Guerra U, Lagonigro SM, Forloni B, Barni S. Eur J Gastroenterol Hepatol; 2007 Aug 21; 19(8):711-3. PubMed ID: 17625442 [Abstract] [Full Text] [Related]
11. Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822Y. Thalheimer A, Schlemmer M, Bueter M, Merkelbach-Bruse S, Schildhaus HU, Buettner R, Hartung E, Thiede A, Meyer D, Fein M, Maroske J, Wardelmann E. Am J Surg Pathol; 2008 Oct 21; 32(10):1560-5. PubMed ID: 18724244 [Abstract] [Full Text] [Related]
12. Gastrointestinal stromal tumors with KIT exon 9 mutations: Update on genotype-phenotype correlation and validation of a high-resolution melting assay for mutational testing. Künstlinger H, Huss S, Merkelbach-Bruse S, Binot E, Kleine MA, Loeser H, Mittler J, Hartmann W, Hohenberger P, Reichardt P, Büttner R, Wardelmann E, Schildhaus HU. Am J Surg Pathol; 2013 Nov 21; 37(11):1648-59. PubMed ID: 24061512 [Abstract] [Full Text] [Related]
13. High-resolution melting analysis is a sensitive diagnostic tool to detect imatinib-resistant and imatinib-sensitive PDGFRA exon 18 mutations in gastrointestinal stromal tumors. Künstlinger H, Binot E, Merkelbach-Bruse S, Huss S, Wardelmann E, Buettner R, Schildhaus HU. Hum Pathol; 2014 Mar 21; 45(3):573-82. PubMed ID: 24444465 [Abstract] [Full Text] [Related]
14. Pathology of gastrointestinal stromal tumors. Hirota S, Isozaki K. Pathol Int; 2006 Jan 21; 56(1):1-9. PubMed ID: 16398673 [Abstract] [Full Text] [Related]
15. Familial gastrointestinal stromal tumor syndrome: report of 2 cases with KIT exon 11 mutation. Jones DH, Caracciolo JT, Hodul PJ, Strosberg JR, Coppola D, Bui MM. Cancer Control; 2015 Jan 21; 22(1):102-8. PubMed ID: 25504284 [Abstract] [Full Text] [Related]
16. Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital. Yeh CN, Chen TW, Lee HL, Liu YY, Chao TC, Hwang TL, Jan YY, Chen MF. Ann Surg Oncol; 2007 Mar 21; 14(3):1123-8. PubMed ID: 17195905 [Abstract] [Full Text] [Related]
17. Mutations in gastrointestinal stromal tumors diagnosed by endoscopic ultrasound-guided fine needle aspiration. Schmitt FC, Gomes AL, Milanezi F, Reis R, Bardales RH. Minerva Med; 2007 Aug 21; 98(4):385-8. PubMed ID: 17921955 [Abstract] [Full Text] [Related]
18. Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment. Yeh CN, Chen TW, Tseng JH, Liu YY, Wang SY, Tsai CY, Chiang KC, Hwang TL, Jan YY, Chen MF. J Surg Oncol; 2010 Nov 01; 102(6):599-603. PubMed ID: 20976730 [Abstract] [Full Text] [Related]
19. Practical role of mutation analysis for imatinib treatment in patients with advanced gastrointestinal stromal tumors: a meta-analysis. Zhi X, Zhou X, Wang W, Xu Z. PLoS One; 2013 Nov 01; 8(11):e79275. PubMed ID: 24223922 [Abstract] [Full Text] [Related]
20. Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1. Mussi C, Schildhaus HU, Gronchi A, Wardelmann E, Hohenberger P. Clin Cancer Res; 2008 Jul 15; 14(14):4550-5. PubMed ID: 18628470 [Abstract] [Full Text] [Related] Page: [Next] [New Search]